Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT05966233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
ClinicalTrials.gov study NCT05571540. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
ClinicalTrials.gov study NCT06789159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
ClinicalTrials.gov study NCT02741388. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
ClinicalTrials.gov study NCT05784441. IPD Sharing: YES. Countries: 4. Publications: 0.
Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
ClinicalTrials.gov study NCT06508931. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00735930. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05933967. IPD Sharing: Not stated. Countries: 1. Publications: 0.
KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma
ClinicalTrials.gov study NCT02471911. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07365306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ClinicalTrials.gov study NCT05890352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
ClinicalTrials.gov study NCT04824950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma
ClinicalTrials.gov study NCT04899570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma
ClinicalTrials.gov study NCT06670105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)
ClinicalTrials.gov study NCT06539195. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03513601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia
ClinicalTrials.gov study NCT04714593. IPD Sharing: YES. Countries: 1. Publications: 0.
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06056752. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
ClinicalTrials.gov study NCT00925925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients
ClinicalTrials.gov study NCT04164368. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.